SCHEMBL4860149

SCHEMBL4860149

CNC(C)C=C(C)C(N)=O

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.31
LMNA P02545 1/20 0.30
ALOX15 P16050 1/20 0.30
BLM P54132 1/20 0.30
PMP22 Q01453 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15710709 1.00 TDP1 (0.31) TDP1LMNAALOX15BLMPMP22
SCHEMBL11669926 0.80
SCHEMBL7160453 0.80 NPC1 (0.32)
SCHEMBL1537984 0.79 TUBB1 (0.32)
SCHEMBL1347094 0.79 TUBB1 (0.32)
SCHEMBL4860858 0.77 KDM4E (0.31)
SCHEMBL11909365 0.77 CHRNA1 (0.30)
SCHEMBL12391156 0.76 ALDH1A1 (0.36)
SCHEMBL14950 0.75
SCHEMBL2487818 0.75 LMNA (0.37) TDP1LMNAALOX15BLMPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562091-A1 EMULSION POLYMERS AND METHODS FOR IMPROVING PUMPABILITY ChampionX LLC (US) 2025-06-04 EP disclosed
US-12187959-B2 Emulsion polymers and methods for improving pumpability CHAMPIONX LLC (US) 2025-01-07 US disclosed
US-20240034922-A1 EMULSION POLYMERS AND METHODS FOR IMPROVING PUMPABILITY CHAMPIONX LLC 2024-02-01 US disclosed
WO-2024026442-A1 EMULSION POLYMERS AND METHODS FOR IMPROVING PUMPABILITY CHAMPIONX LLC (US) 2024-02-01 WO disclosed
EP-3328948-A1 COMPOSITIONS CONTAINING POLYANION, ETHOXYLATED CATIONIC POLYMER AND PHYLLOSILICATES FOR IMPROVED OXYGEN BARRIER COATINGS BASF SE (DE) 2018-06-06 EP disclosed
CN-103097954-B Positive photosensitive resin composition, method of creating resist pattern, and electronic component 日立化成株式会社 2017-05-03 CN disclosed
WO-2017017146-A1 COMPOSITIONS CONTAINING POLYANION, ETHOXYLATED CATIONIC POLYMER AND PHYLLOSILICATES FOR IMPROVED OXYGEN BARRIER COATINGS BASF SE (DE) 2017-02-02 WO disclosed
US-20160257686-A1 Purinone Derivatives as Tyrosine Kinase Inhibitors PRINCIPIA BIOPHARMA INC. (US) 2016-09-08 US disclosed
US-20140142099-A1 Purinone Derivatives as Tyrosine Kinase Inhibitors PRINCIPIA BIOPHARMA INC. (US) 2014-05-22 US disclosed
US-7442244-B2 Water-base ink composition SEIKO EPSON CORPORATION (JP) 2008-10-28 US disclosed
EP-1688465-A1 WATER-BASED INK COMPOSITION AND METHOD OF INK-JET RECORDING WITH THE SAME SEIKO EPSON CORPORATION (JP) 2006-08-09 EP disclosed
US-20050235870-A1 2-ethyl-1,3-hexanediol, acetylene glycol surfactant and/or penetrating organic solvent, and humectant; ink jet printing; highly stably ejected and evenly printed on recording media; clogged nozzle problem prevented SEIKO EPSON CORPORATION 2005-10-27 US disclosed
CN-1642998-A Basic polymers obtained by hydrogenation STOCKHAUSEN CHEM FAB GMBH (DE) 2005-07-20 CN disclosed
US-6877851-B2 Ink set for ink jet recording, ink jet recording process, and recorded matter SEIKO EPSON CORPORATION (JP) 2005-04-12 US disclosed
US-20040239738-A1 Ink set for ink jet recording, ink jet recording process, and recorded matter SEIKO EPSON CORPORATION 2004-12-02 US disclosed
EP-0606742-B1 Bile acid sequestrant ROHM & HAAS (US) 1997-11-19 EP disclosed
US-5451397-A Crosslinked amino functional acrylic amide polymer, reducing blood cholesterol levels ROHM AND HAAS COMPANY (US) 1995-09-19 US disclosed
EP-0606742-A1 Bile acid sequestrant ROHM AND HAAS COMPANY (US) 1994-07-20 EP disclosed
EP-0289330-A2 Thermoplastic spun conjugate fibers and nonwoven molding thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-11-02 EP disclosed
WO-1983002115-A1 CATIONIC ACRYLAMIDE AND RUBBER MODIFIED ASPHALTS OWENS CORNING FIBERGLASS CORP (US) 1983-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142099-A1 Purinone Derivatives as Tyrosine Kinase Inhibitors BMX, BLK, ITK TDP1 1189/4885LMNA 4213/4885ALOX15 1353/4885
US-20160257686-A1 Purinone Derivatives as Tyrosine Kinase Inhibitors BMX, BLK, ITK TDP1 1189/4885LMNA 4213/4885ALOX15 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.